Skip to content
Yog Pharma
CardiovascularHMG-CoA reductase inhibitor (statin)

Rosuvastatin Calcium is an HMG-CoA reductase inhibitor (statin) indicated for hyperlipidemia, hypertriglyceridemia and prevention of cardiovascular disease. We supply it to US manufacturers of tablets and capsules.

CAS147098-20-21001.1 g/molC44H54CaF2N6O12S2
2D structure of Rosuvastatin Calcium, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 5282455) and FDA’s substance registry

CAS number

147098-20-2

Molecular formula

C44H54CaF2N6O12S2

Molecular weight

1001.1g/mol

FDA UNII

IUPAC name

calcium bis((E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate)

InChIKey

LALFOYNTGMUKGG-BGRFNVSISA-L

Appearance
White to almost white, hygroscopic powder.
Solubility
Slightly soluble in water and freely soluble in methylene chloride.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Amorphous and hygroscopic, and it degrades with light, heat and moisture. Ask how the source packs and ships it, and what water content limit it releases to.

On the US market

Reference product
CrestorNDA 021366
Approved ANDAs
19 with a marketed product
Approved forms and strengths
  • Tablet 5 mg, 10 mg, 20 mg, 40 mg

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com